Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-020522
Filing Date
2017-10-31
Accepted
2017-10-31 16:06:22
Documents
70
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qtnt-10q_20170930.htm 10-Q 2221550
2 EX-31.1 qtnt-ex311_148.htm EX-31.1 16423
3 EX-31.2 qtnt-ex312_149.htm EX-31.2 16462
4 EX-32.1 qtnt-ex321_146.htm EX-32.1 5177
5 EX-32.2 qtnt-ex322_147.htm EX-32.2 5152
  Complete submission text file 0001564590-17-020522.txt   7615919

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qtnt-20170930.xml EX-101.INS 1651983
7 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20170930.xsd EX-101.SCH 48320
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20170930_cal.xml EX-101.CAL 62789
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20170930_def.xml EX-101.DEF 191314
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20170930_lab.xml EX-101.LAB 385060
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20170930_pre.xml EX-101.PRE 332272
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-36415 | Film No.: 171165767
SIC: 2835 In Vitro & In Vivo Diagnostic Substances